XNOM, North Shore-LIJ to Begin Prenatal DNA Test Studies

Xenomics, a developer of next-generation medical DNA technologies, has executed a contract with North Shore-Long Island Jewish (LIJ) Health System to begin conducting human clinical studies in the next development phase of the company's Transrenal-DNA (Tr-DNA) technology. The study will test the technology's ability to non-invasively detect Down syndrome in unborn babies using a safe and simple urine collection from the mother.

MENAFN

(http://menafn.com/qn_news_story.asp?StoryId=CqN7GqbKbmti5yJC3od)